MIRA Pharmaceuticals, Inc.
MIRA
$0.96
-$0.01-1.24%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 11.03M | 7.54M | 730.50K | 1.21M | 2.83M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 28.10K | 61.90K | 102.40K | 158.60K | 54.70K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 11.06M | 7.60M | 832.90K | 1.36M | 2.89M |
|
|
|||||
| Total Current Assets | 11.06M | 7.60M | 832.90K | 1.36M | 2.89M |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 35.40K | 35.40K | 35.40K | 35.40K | 35.40K |
| Total Assets | 11.09M | 7.63M | 868.30K | 1.40M | 2.92M |
|
|
|||||
| Total Accounts Payable | 129.20K | 83.90K | 298.50K | 100.70K | 723.30K |
| Total Accrued Expenses | -- | -- | -- | 5.50K | -- |
| Short-term Debt | 572.90K | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 702.10K | 83.90K | 298.50K | 106.20K | 723.30K |
|
|
|||||
| Total Current Liabilities | 702.10K | 83.90K | 298.50K | 106.20K | 723.30K |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | 572.90K | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 702.10K | 83.90K | 298.50K | 106.20K | 723.30K |
|
|
|||||
| Common Stock & APIC | 49.97M | 41.15M | 33.03M | 32.22M | 31.34M |
| Retained Earnings | -39.58M | -33.60M | -32.46M | -30.92M | -29.14M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 10.39M | 7.55M | 569.90K | 1.29M | 2.20M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 10.39M | 7.55M | 569.90K | 1.29M | 2.20M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 10.39M | 7.55M | 569.90K | 1.29M | 2.20M |
|
|
|||||